Comparison of a Novel 22-gauge Core Biopsy Needle

Completed · Not applicable

Conditions studied: Solid Pancreatic Mass Lesions, Malignant Neoplasm of Pancreas

In brief

The goal of this clinical research study is to compare the performance of a newly available needle with reverse bevel design (called the EchoTip® Procore™ needle) with standard needles to see which needle gives better diagnostic information for pancreatic lesions.

Key facts

Study ID

NCT01598194

Run by

M.D. Anderson Cancer Center

People needed

60

Starts

2012-01-30

Expected to finish

2017-07-06

Last updated by the study team

2018-12-27

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patient age 18 years and older.
• All patients referred for EUS FNA of endoscopically accessible solid pancreatic lesions.

You may not qualify if…

• Unable to obtain informed consent.
• Unable to tolerate the procedure.
• Women with known pregnancy at time.
• Patient age less than 18 years of age.
• Bleeding diathesis
• Cystic pancreatic lesions
• Lesion not accessible by EUS guided FNA

Where it is running

• University of Texas MD Anderson Cancer Center — Houston, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.